Journal
PAIN
Volume 93, Issue 1, Pages 69-76Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0304-3959(01)00294-9
Keywords
vinca alkaloids; neuropathic pain; allodynia; chemotherapy; hyperalgesia
Categories
Funding
- NINDS NIH HHS [NS 01769] Funding Source: Medline
Ask authors/readers for more resources
The aims of this study were two-fold: first, to simplify the method for creating a recently described neuropathic pain model in the rat, and second, to evaluate the effects of a number of drugs with analgesic or antihyperalgesic properties, in this model. Continuous intravenous vincristine infusion(1-100 mug kg(-1) day(-1)) for 14 days resulted in a dose dependent tactile allodynia las measured by L-on Frey. filaments) by 7 days at doses between 30 - 100 mug kg(-1) day(-1), with a hindlimb motor deficit observed at doses greater than 50 mug kg (-1) day (-1). No thermal hyperalgesia was observed. Systemic morphine, lidocaine, mexiletine and pregabalin (given intraperitoneally) produced significant reduction of the allodynia, while tetrodotoxin was without effect. Continuous intravenous infusion of vincristine in rats thus provides a reliable model of chemotherapy induced neuropathy which may be used in defining the mechanism and pharmacology of this clinically relevant condition. (C) 2001 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available